SEARCH

SEARCH BY CITATION

References

  • Al-Jarrah, M., Pothakos, K., Novikova, L., Smirnova, I.V., Kurz, M.J., Stehno-Bittel, L. & Lau, Y.S. (2007) Endurance exercise promotes cardiorespiratory rehabilitation without neurorestoration in the chronic mouse model of parkinsonism with severe neurodegeneration. Neuroscience, 149, 2837.
  • Baatile, J., Langbein, W.E., Weaver, F., Maloney, C. & Jost, M.B. (2000) Effect of exercise on perceived quality of life of individuals with Parkinson’s disease. J. Rehabil. Res. Dev., 37, 529534.
  • Barber-Singh, J., Seo, B.B., Nakamaru-Ogiso, E., Lau, Y.S., Matsuno-Yagi, A. & Yagi, T. (2009) Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder. Rejuvenation Res, 12, 259267.
  • Beal, M.F. (2002) Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med., 32, 797803.
  • Beal, M.F. (2005) Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol., 58, 495505.
  • Bender, A., Krishnan, K.J., Morris, C.M., Taylor, G.A., Reeve, A.K., Perry, R.H., Jaros, E., Hersheson, J.S., Betts, J., Klopstock, T., Taylor, R.W. & Turnbull, D.M. (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet., 38, 515517.
  • Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V. & Greenamyre, J.T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat. Neurosci., 3, 13011306.
  • Betarbet, R., Sherer, T.B., Di Monte, D.A. & Greenamyre, J.T. (2002) Mechanistic approaches to Parkinson’s disease pathogenesis. Brain Pathol., 12, 499510.
  • Calabrese, V., Scapagnini, G., Giuffrida Stella, A.M., Bates, T.E. & Clark, J.B. (2001) Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res., 26, 739764.
  • Chauhan, N.B., Siegel, G.J. & Lee, J.M. (2001) Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson’s disease brain. J. Chem. Neuroanat., 21, 277288.
  • Cheng, F.C., Ni, D.R., Wu, M.C., Kuo, J.S. & Chia, L.G. (1998) Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice. Neurosci. Lett., 252, 8790.
  • Cohen, A.D., Tillerson, J.L., Smith, A.D., Schallert, T. & Zigmond, M.J. (2003) Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J. Neurochem., 85, 299305.
  • Comella, C.L., Stebbins, G.T., Brown-Toms, N. & Goetz, C.G. (1994) Physical therapy and Parkinson’s disease: a controlled clinical trial. Neurology, 44, 376378.
  • Conley, K.E., Jubrias, S.A., Amara, C.E. & Marcinek, D.J. (2007) Mitochondrial dysfunction: impact on exercise performance and cellular aging. Exerc. Sport Sci. Rev., 35, 4349.
  • Cotman, C.W. & Berchtold, N.C. (2002) Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci., 25, 295301.
  • Darios, F., Corti, O., Lucking, C.B., Hampe, C., Muriel, M.P., Abbas, N., Gu, W.J., Hirsch, E.C., Rooney, T., Ruberg, M. & Brice, A. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet., 12, 517526.
  • Drucker-Colin, R. & Garcia-Hernandez, F. (1991) A new motor test sensitive to aging and dopaminergic function. J. Neurosci. Methods, 39, 153161.
  • Ekstrand, M.I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F.S., Trifunovic, A., Hoffer, B., Cullheim, S., Mohammed, A.H., Olson, L. & Larsson, N.G. (2007) Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc. Natl Acad. Sci. USA, 104, 13251330.
  • Eldar, R. & Marincek, C. (2000) Physical activity for elderly persons with neurological impairment: a review. Scand. J. Rehabil. Med., 32, 99103.
  • Fisher, B.E., Petzinger, G.M., Nixon, K., Hogg, E., Bremmer, S., Meshul, C.K. & Jakowec, M.W. (2004) Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J. Neurosci. Res., 77, 378390.
  • Fornai, F., Schluter, O.M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C.L., Pontarelli, F., Battaglia, G., Pellegrini, A., Nicoletti, F., Ruggieri, S., Paparelli, A. & Sudhof, T.C. (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc. Natl Acad. Sci. USA, 102, 34133418.
  • Haskell, W.L., Lee, I.M., Pate, R.R., Powell, K.E., Blair, S.N., Franklin, B.A., Macera, C.A., Heath, G.W., Thompson, P.D. & Bauman, A. (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation, 116, 10811093.
  • Hennigan, A., O’Callaghan, R.M. & Kelly, A.M. (2007) Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem. Soc. Trans., 35, 424427.
  • Howells, D.W., Porritt, M.J., Wong, J.Y., Batchelor, P.E., Kalnins, R., Hughes, A.J. & Donnan, G.A. (2000) Reduced BDNF mRNA expression in the Parkinson’s disease substantia nigra. Exp. Neurol., 166, 127135.
  • Lau, Y.S. (2005). Progressive neurodegeneration in the MPTP/probenecid model of Parkinson’s disease. In Ebadi, M. & Pfeiffer, R. (Eds), Parkinson’s Disease. CRC Press, Boca Raton, FL, pp. 109115.
  • Lau, Y.S., Trobough, K.L., Crampton, J.M. & Wilson, J.A. (1990) Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Gen. Pharmacol., 21, 181187.
  • Lau, Y.S., Novikova, L. & Roels, C. (2005) MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact. Neurosci. Res., 52, 371378.
  • Mabandla, M., Kellaway, L., St Clair Gibson, A. & Russell, V.A. (2004) Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle. Metab. Brain Dis., 19, 4350.
  • Mattson, M.P. (2000) Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res., 886, 4753.
  • Meredith, G.E., Totterdell, S., Petroske, E., Santa Cruz, K., Callison, R.C. Jr & Lau, Y.S. (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson’s disease. Brain Res., 956, 156165.
  • Miyai, I., Fujimoto, Y., Ueda, Y., Yamamoto, H., Nozaki, S., Saito, T. & Kang, J. (2000) Treadmill training with body weight support: its effect on Parkinson’s disease. Arch. Phys. Med. Rehabil., 81, 849852.
  • Navarro, A. & Boveris, A. (2007) Brain mitochondrial dysfunction in aging: conditions that improve survival, neurological performance and mitochondrial function. Front Biosci, 12, 11541163.
  • Novikova, L., Garris, B.L., Garris, D.R. & Lau, Y.S. (2006) Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson’s disease. Neuroscience, 140, 6776.
  • Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C., Wacker, M., Klose, J. & Shen, J. (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem, 279, 1861418622.
  • Parain, K., Murer, M.G., Yan, Q., Faucheux, B., Agid, Y., Hirsch, E. & Raisman-Vozari, R. (1999) Reduced expression of brain-derived neurotrophic factor protein in Parkinson’s disease substantia nigra. Neuroreport, 10, 557561.
  • Patki, G., Che, Y. & Lau, Y.S. (2009) Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson’s disease. Front Aging Neurosci, 1, 3.
  • Pereira, A.C., Huddleston, D.E., Brickman, A.M., Sosunov, A.A., Hen, R., McKhann, G.M., Sloan, R., Gage, F.H., Brown, T.R. & Small, S.A. (2007) An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc. Natl Acad. Sci. USA, 104, 56385643.
  • Petroske, E., Meredith, G.E., Callen, S., Totterdell, S. & Lau, Y.S. (2001) Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience, 106, 589601.
  • Pothakos, K., Kurz, M.J. & Lau, Y.S. (2009) Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson’s disease with severe neurodegeneration. BMC Neurosci, 10, 6.
  • Poulton, N.P. & Muir, G.D. (2005) Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-parkinsonian rats. Exp. Neurol., 193, 181197.
  • van Praag, H., Shubert, T., Zhao, C. & Gage, F.H. (2005) Exercise enhances learning and hippocampal neurogenesis in aged mice. J. Neurosci., 25, 86808685.
  • Reuter, I., Engelhardt, M., Stecker, K. & Baas, H. (1999) Therapeutic value of exercise training in Parkinson’s disease. Med. Sci. Sports Exerc., 31, 15441549.
  • Schallert, T., Woodlee, M.T. & Fleming, S.M. (2002) Disentangling multiple types of recovery from brain injury. In Krieglstein, J. & Klumpp, S. (Eds), Pharmacology of Cerebral Ischemia. Medpharm Scientific Publishers, Stuttgart, Germany, pp. 201216.
  • Scott, S.A., Diaz, N.M. & Ahmad, S.O. (2007) Stereologic analysis of cell number and size during postnatal development in the rat substantia nigra. Neurosci. Lett., 419, 3437.
  • Smith, A.D. & Zigmond, M.J. (2003) Can the brain be protected through exercise? Lessons from an animal model of parkinsonism Exp. Neurol., 184, 3139.
  • Song, D.D., Shults, C.W., Sisk, A., Rockenstein, E. & Masliah, E. (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol., 186, 158172.
  • Tajiri, N., Yasuhara, T., Shingo, T., Kondo, A., Yuan, W., Kadota, T., Wang, F., Baba, T., Tayra, J.T., Morimoto, T., Jing, M., Kikuchi, Y., Kuramoto, S., Agari, T., Miyoshi, Y., Fujino, H., Obata, F., Takeda, I., Furuta, T. & Date, I. (2010) Exercise exerts neuroprotective effects on Parkinson’s disease model of rats. Brain Res., 1310, 200207.
  • Tang, F.I., Tien, L.T., Zhou, F.C., Hoffer, B.J. & Wang, Y. (1998) Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Exp. Brain Res., 119, 287296.
  • Thyagarajan, D., Bressman, S., Bruno, C., Przedborski, S., Shanske, S., Lynch, T., Fahn, S. & DiMauro, S. (2000) A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann. Neurol., 48, 730736.
  • Tillerson, J.L., Caudle, W.M., Reveron, M.E. & Miller, G.W. (2003) Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson’s disease. Neuroscience, 119, 899911.
  • Wang, G.J., Volkow, N.D., Fowler, J.S., Franceschi, D., Logan, J., Pappas, N.R., Wong, C.T. & Netusil, N. (2000) PET studies of the effects of aerobic exercise on human striatal dopamine release. J. Nucl. Med., 41, 13521356.
  • Xu, J., Kao, S.Y., Lee, F.J., Song, W., Jin, L.W. & Yankner, B.A. (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med., 8, 600606.